29 Apr, 2020 image
search_img

Fasten Your Seatbelts, It’s Wheels Up for On-demand Healthcare

During a time when other industries have been grounded, the telemedicine industry has taken off into the mainstream, fueled by the global health crisis. In an effort to assess the sustainability of this growth, we conducted a survey of 1,015 consumers across the U.S., at varying ages and income levels. As telemedicine emerges as one of the most transformative themes in healthcare tech today, we have identified multiple vectors that could further fuel growth for years to come, such as repeat visits, mental health, and chronic condition management. Telemedicine’s rapid growth is just one of many key contributors to the ROBO Global Healthcare Technology and Innovation Index (HTEC) year-to-date outperformance of +5%, compared to global equities, down -12%.*

First Time Telemedicine Use Has More Than Tripled Its Pre-Pandemic Run Rate

In a recent survey, we asked 1,015 consumers whether they have tried telemedicine at least once, and if so, when. Over half of respondents indicated that they have used it. We view this as substantial because only a few years ago, most consumers had not yet tried telemedicine. Of those who have used it, 52% tried telemedicine for the first time during the pandemic this year. This represents a more than three-fold increase in first-time telemedicine users during the pandemic, compared with 14% before the pandemic.

Source: ROBO Global

 

There’s No Going Back

One may wonder if this growth is just a static event driven by COVID-19 stay-at-home requirements. However, history has shown that once someone uses telemedicine once, there is a greater likelihood of that person using it again. For the last three years, Teladoc Health, a member of the HTEC Index, reported that the number of visits from repeat users was greater than the number of visits from new users.

Looking forward, we asked our respondents who have used telemedicine what their likelihood is of using it again. The vast majority (93%) indicated they would use it again, with 59% indicating that they were very likely to use it again.

Source: ROBO Global

 

Of the respondents who have NOT used telemedicine, 25% said they were definitely planning to try telemedicine for general visits. This, among other data points from our research, provides us with a high conviction that for most consumers, telemedicine is only just getting started, and that multiple vectors will fuel growth in this industry for years to come.

Download the full report here.

 

About HTEC

Healthcare is undergoing a rapid technological transformation. The ROBO Global Healthcare Technology and Innovation Index (HTEC) provides investors with exposure to this innovation, 80+ companies that we believe are leading the way across the fastest-growing areas of healthcare, including telehealth, genomics, precision medicine, robotics, and more. With HTEC, investors will be well-positioned to capture the upside of healthcare’s technological revolution for years to come.

 

*Data as of April 29, 2020

You are now leaving the ROBO Global website

You are now leaving the ROBO Global website. The following landing page may contain information concerning investments, products or other information. Exchange Traded Concepts LLC, the Fund Advisor are not responsible for the accuracy or completeness of information on non-affiliated websites. The material available on non-affiliated websites has been produced by the entities that are not affiliated with Exchange Traded Concepts LLC. Descriptions of, references to, or links to products or publications within any non-affiliated linked website does not imply endorsement of that product or publication by Exchange Traded Concepts LLC. Any opinions or recommendations from non-affiliated websites are solely those of the independent providers and are not the opinions or recommendations of Exchange Traded Concepts LLC, which is not responsible for any inaccuracies or errors.

Proceed

Dismiss

You are now leaving the ROBO Global website

You are now leaving the ROBO Global, LLC website and being directed to ETF Securities (UK) Limited which is authorized and regulated by the United Kingdom Financial Conduct Authority (the “FCA”). By clicking “OK”, you acknowledge that you are someone authorized to undertake investment activities relating to the Exchange Traded Funds (ETFs). IN addition, you understand that ROBO Global, LLC is not making any financial promotion or carrying out any regulated activity of said products. The following landing page may contain information concerning investments, products or other information. ETF Securities (UK) Limited is not responsible for the accuracy or completeness of information on non-affiliated websites. The material available on non-affiliated websites has been produced by entities that are not affiliated with ETF Securities (UK) Limited. Descriptions of references to, or links to products or publications within any non-affiliated linked websites does not imply endorsement of that product or publication by ETF Securities (UK) Limited. Any opinions or recommendations from non-affiliated websites are solely those of the independent providers and are not the opinions or recommendations of ETF Securities (UK) Limited, which is not responsible for any inaccuracies or errors.

Proceed

Dismiss

You are now leaving the ROBO Global website

You are now leaving the ROBO Global, LLC website and being directed to ETFS Management (AUS) Limited which is authorized and regulated by the Australian Securities and Investments Commission (“ASIC“). By clicking “OK”, you acknowledge that you are someone authorized to undertake investment activities relating to the Exchange Traded Funds (ETFs). In addition, you understand that ROBO Global, LLC is not making any financial promotion or carrying out any regulated activity of said products. The following landing page may contain information concerning investments, products or other information. ETFS Management (AUS) Limited is not responsible for the accuracy or completeness of information on non-affiliated websites. The material available on non-affiliated websites has been produced by entities that are not affiliated with ETFS Management (AUS) Limited. Descriptions of references to, or links to products or publications within any non-affiliated linked websites does not imply endorsement of that product or publication by ETFS Management (AUS) Limited. Any opinions or recommendations from non-affiliated websites are solely those of the independent providers and are not the opinions or recommendations of ETFS Management (AUS) Limited, which is not responsible for any inaccuracies or errors.

Proceed

Dismiss